272 related articles for article (PubMed ID: 19397838)
1. Transcription factors in the pathogenesis of diabetic nephropathy.
Sanchez AP; Sharma K
Expert Rev Mol Med; 2009 Apr; 11():e13. PubMed ID: 19397838
[TBL] [Abstract][Full Text] [Related]
2. Diabetic nephropathy: where hemodynamics meets metabolism.
Forbes JM; Fukami K; Cooper ME
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
[TBL] [Abstract][Full Text] [Related]
3. Astaxanthin protects mesangial cells from hyperglycemia-induced oxidative signaling.
Manabe E; Handa O; Naito Y; Mizushima K; Akagiri S; Adachi S; Takagi T; Kokura S; Maoka T; Yoshikawa T
J Cell Biochem; 2008 Apr; 103(6):1925-37. PubMed ID: 17955498
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of diabetic nephropathy.
Raptis AE; Viberti G
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S424-37. PubMed ID: 11460589
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
Daniel C; Schaub K; Amann K; Lawler J; Hugo C
Diabetes; 2007 Dec; 56(12):2982-9. PubMed ID: 17878288
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.
Ahn JD; Morishita R; Kaneda Y; Kim HJ; Kim YD; Lee HJ; Lee KU; Park JY; Kim YH; Park KK; Chang YC; Yoon KH; Kwon HS; Park KG; Lee IK
Gene Ther; 2004 Jun; 11(11):916-23. PubMed ID: 14961072
[TBL] [Abstract][Full Text] [Related]
7. Kidney involvement and disease in patients with diabetes.
Chiarelli F; Trotta D; Verrotti A; Mohn A
Panminerva Med; 2003 Mar; 45(1):23-41. PubMed ID: 12682618
[TBL] [Abstract][Full Text] [Related]
8. RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.
Peng F; Wu D; Gao B; Ingram AJ; Zhang B; Chorneyko K; McKenzie R; Krepinsky JC
Diabetes; 2008 Jun; 57(6):1683-92. PubMed ID: 18356410
[TBL] [Abstract][Full Text] [Related]
9. New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.
Wolf G
Eur J Clin Invest; 2004 Dec; 34(12):785-96. PubMed ID: 15606719
[TBL] [Abstract][Full Text] [Related]
10. Intrarenal oxygen in diabetes and a possible link to diabetic nephropathy.
Palm F
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):997-1001. PubMed ID: 17002679
[TBL] [Abstract][Full Text] [Related]
11. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy.
Cooper ME
Diabetologia; 2001 Nov; 44(11):1957-72. PubMed ID: 11719827
[TBL] [Abstract][Full Text] [Related]
12. Role of TGF-beta in pathogenesis of diabetic nephropathy.
Pantsulaia T
Georgian Med News; 2006 Feb; (131):13-8. PubMed ID: 16575121
[TBL] [Abstract][Full Text] [Related]
13. Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.
Ichinose K; Kawasaki E; Eguchi K
Am J Nephrol; 2007; 27(6):554-64. PubMed ID: 17823503
[TBL] [Abstract][Full Text] [Related]
14. Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB.
Chiu J; Khan ZA; Farhangkhoee H; Chakrabarti S
Nutrition; 2009 Sep; 25(9):964-72. PubMed ID: 19268536
[TBL] [Abstract][Full Text] [Related]
15. The use of transgenic animals in the study of diabetic kidney disease.
Wogensen L; Krag S; Chai Q; Ledet T
Horm Metab Res; 2005 Apr; 37 Suppl 1():17-25. PubMed ID: 15918106
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of diabetic nephropathy.
Dronavalli S; Duka I; Bakris GL
Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
[TBL] [Abstract][Full Text] [Related]
17. Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.
Ziyadeh FN
Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S38-41. PubMed ID: 18842317
[TBL] [Abstract][Full Text] [Related]
18. Diabetic nephropathy: from mechanisms to rational therapies.
Giunti S; Barit D; Cooper ME
Minerva Med; 2006 Jun; 97(3):241-62. PubMed ID: 16855519
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating transforming growth factor beta-1 may explain poorer renal survival in type II diabetics with chronic hepatitis C.
Peterson MC
Med Sci Monit; 2007 May; 13(5):RA81-5. PubMed ID: 17476201
[TBL] [Abstract][Full Text] [Related]
20. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.
Navarro JF; Mora-Fernández C
Cytokine Growth Factor Rev; 2006 Dec; 17(6):441-50. PubMed ID: 17113815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
